Concepedia

Edward Pratt

EP

13

Publications

1.1K

Citations

13

H-Index

2002

Active since

Affiliations

Eli Lilly (United States)(Current)

Profil Institute for Metabolic Research

Eli Lilly (Singapore)

Clinical Nutrition Research Centre

Velocity Clinical Research (United States)

Edward Pratt is an author at Eli Lilly (United States) specializing in medicine, metabolic syndrome, and diabetes.

ORCID

Top concepts

Publications per year

2002–2025

13

Publications

13

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

Sean Wharton, Thomas Blevins, Lisa Connery et al. · New England Journal of Medicine · 2023 · 378 citations

Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes

Tim Heise, J. Hans DeVries, Shweta Urva et al. · Diabetes Care · 2023 · 169 citations · Full text

Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study

Juan P. Frías, Stanley H. Hsia, Sarah Eyde et al. · The Lancet · 2023 · 135 citations

, , +8

Alcohol consumption alters insulin secretion and cardiac autonomic activity

Daniel Flanagan, Edward Pratt, June Murphy et al. · European Journal of Clinical Investigation · 2002 · 64 citations

Pharmacokinetic and pharmacodynamic properties of the novel basal insulin Fc (insulin efsitora alfa), an insulin fusion protein in development for once‐weekly dosing for the treatment of patients with diabetes

Tim Heise, Jenny Y. Chien, John M. Beals et al. · Diabetes Obesity and Metabolism · 2022 · 63 citations

Rows per page

1–5 of 13